Louis F. Diehl, MD is a professor of medicine at Duke University School of Medicine with a long-standing interest and involvement in the staging and treatment of hematologic malignancies. He recently served as chairperson of the 2016 Asheville Hematologic Malignancies Symposium where Oncology Data Advisor spoke with him about the evolving standards of care in hematologic malignancies, the challenges of incorporating biosimilars in contemporary practice, and advances specific to follicular lymphoma treatment.

Discussion Notes: On the evolving standards of care in hematologic malignancies [1:38] On the challenges of incorporating biosimilars in contemporary practice [3:25] On new advances in follicular lymphoma treatment [4:16]